structure of PIPERIDIN-4-YL-QUINOLIN-3-YL-METHANONE

PIPERIDIN-4-YL-QUINOLIN-3-YL-METHANONE

CAS No.: 1073944-16-7
M. Wt: 240.30000
M. Fa: C15H16N2O
InChI Key: -

Names and Identifiers of PIPERIDIN-4-YL-QUINOLIN-3-YL-METHANONE

CAS Number

1073944-16-7

IUPAC Name

piperidin-4-yl(quinolin-3-yl)methanone

Canonical SMILES

C1CNCCC1C(=O)C2=CC3=CC=CC=C3N=C2

Physical and chemical properties of PIPERIDIN-4-YL-QUINOLIN-3-YL-METHANONE

Exact Mass

240.12600

LogP

2.74590

Molecular Formula

C15H16N2O

Molecular Weight

240.30000

PSA

41.99000

Applications of PIPERIDIN-4-YL-QUINOLIN-3-YL-METHANONE

Piperidin-4-yl-quinolin-3-yl-methanone has several notable applications:

  • Pharmaceutical Development: Due to its biological activity, it is being explored as a lead compound for new drugs targeting cancer and neurological disorders.
  • Chemical Research: Its unique structure makes it a valuable compound for studying structure–activity relationships in medicinal chemistry.

Interaction Studies of PIPERIDIN-4-YL-QUINOLIN-3-YL-METHANONE

Interaction studies have demonstrated that piperidin-4-yl-quinolin-3-yl-methanone interacts with various biological targets, including enzymes involved in cancer progression and neurotransmitter regulation. These interactions are critical for understanding its mechanism of action and optimizing its therapeutic potential.

Biological Activity of PIPERIDIN-4-YL-QUINOLIN-3-YL-METHANONE

This compound exhibits significant biological activity, particularly in the fields of oncology and neurology. Research has indicated that piperidin-4-yl-quinolin-3-yl-methanone may possess:

  • Anticancer Properties: It has shown potential in inhibiting cancer cell proliferation and inducing apoptosis in various cancer cell lines, making it a candidate for further development as an anticancer agent.
  • Neuroprotective Effects: Similar compounds have been noted for their ability to inhibit acetylcholinesterase, suggesting potential applications in treating neurodegenerative diseases such as Alzheimer's disease.